[go: up one dir, main page]

Kapustianenko, 2017 - Google Patents

Polyclonal antibodies against human plasminogen kringle 5

Kapustianenko, 2017

View PDF
Document ID
2342293377194952747
Author
Kapustianenko L
Publication year
Publication venue
Biotechnologia Acta

External Links

Snippet

42 of Glu-plasminogen with desAB fibrin and fibrinogen, which is activated by thrombin (polymeric fibrin), and on the activation of plasminogen by tissue plasminogen activator. Also these antibodies can be used to study the effect of the K 5 fragment on the platelet …
Continue reading at www.irbis-nbuv.gov.ua (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors

Similar Documents

Publication Publication Date Title
Nielsen et al. Monoclonal antibodies to human 54,000 molecular weight plasminogen activator inhibitor from fibrosarcoma cells-inhibitor neutralization and one-step affinity purification
Mimuro et al. Monoclonal antibodies to discrete regions in a2-plasmin inhibitor
COLLEN Identification and some properties of a new fast‐reacting plasmin inhibitor in human plasma
Moestrup et al. Analysis of ligand recognition by the purified alpha 2-macroglobulin receptor (low density lipoprotein receptor-related protein). Evidence that high affinity of alpha 2-macroglobulin-proteinase complex is achieved by binding to adjacent receptors
White et al. The isolation and characterization of plasminogen activators (urokinase) from human urine
Stump et al. Purification and characterization of a novel inhibitor of urokinase from human urine. Quantitation and preliminary characterization in plasma.
Laurell et al. FORMATION OF COMPLEXES COMPOSED OF Cr, Cs, AND C INACTIVATOR IN HUMAN SERUM ON ACTIVATION OF C1
JPH0638790A (en) Specific monoclonal antibody against factor- viii:c coagulation factor polypeptides
US6372886B1 (en) Expression and purification of kringle domains of human apolipoprotein (a) in E. coli
Dodds et al. Structural basis of the binding specificity of the thioester-containing proteins, C4, C3 and alpha-2-macroglobulin
Kapustianenko Polyclonal antibodies against human plasminogen kringle 5
Ploplis et al. Monoclonal antibodies to discrete regions of human Glu1-plasminogen
Strickland et al. Identification of a monoclonal antibody specific for a neoantigenic determinant on. alpha. 2-macroglobulin: use for the purification and characterization of binary proteinase-inhibitor complexes
Laurell et al. Characterization of monoclonal antibodies against human protein C specific for the calcium ion‐induced conformation or for the activation peptide region
Lapeyre et al. Production and characterization of monoclonal antibodies to staphylococcal enterotoxins: use in immunodetection and immunopurification
JPH0676438B2 (en) Protein isolated from blood, method for producing the protein, and pharmaceutical composition containing the protein
Veloso et al. A monoclonal anti-human plasma prekallikrein antibody that inhibits activation of prekallikrein by factor XIIa on a surface
Miles et al. Topography of the high-affinity lysine binding site of plasminogen as defined with a specific antibody probe
Wallén et al. The tissue activator of plasminogen
HUMAN et al. EXPERIMENTAL ARTICLES
EP0271810A2 (en) Immunological determination of free human protein s and c4bp-protein s complex
ES2449303T3 (en) System for the determination of an unprocessed and partially processed neurotoxin type A
Goufman et al. Quantification of autoantibodies to plasminogen in plasma of patients with cancer
Kapustianenko et al. Isolation and purification of a kringle 5 from human plasminogen using AH-Sepharose
WO1992011384A1 (en) ANTIBODY AGAINST HUMAN PLASMIN-α2-PLASMIN INHIBITOR COMPLEX, HYBRIDOMA AND IMMUNOASSAY